Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Sarcoidosis and Beryllium Toxicity Research, Chronic Obstructive Pulmonary Disease (COPD) Research, and Lung Cancer Diagnosis and Treatment.
Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implications
Is YouTube a sufficient source of information on Sarcoidosis?
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe
Profibrotic priming of airway cell types and drug responses in early-stage idiopathic pulmonary fibrosis
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
<scp>SARS</scp> ‐CoV‐2 receptor <scp>ACE</scp> 2 and <scp>TMPRSS</scp> 2 are primarily expressed in bronchial transient secretory cells
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease
miR-126 is a potential diagnostic marker for malignant pulmonary nodules in endobronchial epithelial lining fluid
Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules
Early Detection of Lung Cancer by Molecular Markers in Endobronchial Epithelial-Lining Fluid